Stakeholder reporting of facilitators, barriers, and solutions related to FH care.

Figshare2020-12-23 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Stakeholder_reporting_of_facilitators_barriers_and_solutions_related_to_FH_care_/13485368 数据链接链接失效反馈

官方服务：

资源简介：

Stakeholder reporting of facilitators, barriers, and solutions related to FH care.

创建时间：

2020-12-23

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia

遗传病筛查预测

家族性高胆固醇血症管理

Abstract Background: Genetic cascade screening is the most cost-effective method for the identification of individuals with familial hypercholesterolemia (FH), but the best strategies for the enrollm

NIAID Data Ecosystem70

Cardiovascular Risk Misperception and Low Awareness of Familial Hypercholesterolemia in Individuals with Severe Hypercholesterolemia

心血管疾病风险

家族性高胆固醇血症管理

Abstract Background Individuals with severe hypercholesterolemia are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD). Many of them have familial hypercholesterolemia (FH)

NIAID Data Ecosystem50

fdata-01-00004_Systematic Lab Knowledge Integration for Management of Lipid Excess in High-Risk Patients: Rationale and Design of the SKIM LEAN Project.xml

家族性高胆固醇血症管理

临床决策支持系统

SKIM LEAN aims at exploiting Electronic Health Records (EHRs) to integrate knowledge derived from routine laboratory tests with background analysis of clinical databases, for the identification and ea

NIAID Data Ecosystem20

Supplementary Material for: Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA

家族性高胆固醇血症管理

医疗实施科学

Familial hypercholesterolemia (FH) is a genetic condition which causes elevated low-density lipoprotein cholesterol from birth. With a prevalence of 1 in 250 and the availability of effective treatmen

NIAID Data Ecosystem60

A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals

HIV治疗药物

家族性高胆固醇血症管理

BackgroundDrug choice and metabolic changes with antiretroviral therapy contribute to cardiovascular risk in persons with HIV-1 infection.MethodsA randomized, 12 week, open-label, comparative study of

Figshare2016-01-15 更新20

Stakeholder reporting of facilitators, barriers, and solutions related to FH care.

资源简介：

相关数据集